DiscoverLung Cancer ConsideredIASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2
IASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2

IASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2

Update: 2024-10-29
Share

Description

Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21)

Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu previews the upcoming IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC. To discuss this exciting new meeting and this topic, he is joined by the four co-chairs of the meeting. To learn more about the meeting, visit https://www.httr2024-iaslc.org/.

Guest: Dr. Alice Berger is an Associate Professor in the Human Biology Division and the Herbold Computational Biology Program at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, Wash.
X: @aliceb_phd

Guest: Dr. Kenichi Suda, Associate Professor in the Division of Thoracic Surgery at Kindai University School of Medicine in Osaka, Japan.
X: NA

Guest: Dr. Montse Sanchez-Cespedes is the Group Leader at the Josep Carreras Research Institute, in Badalona, Spain
X: @CespedesMontse

Guest: Dr. William Lockwood, Senior Scientist in Integrative Oncology at the BC Cancer Research Institute and Associate Professor in Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, Canada
X: @WWL_18
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

IASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2

IASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2

IASLC